Rhoifolin, an inhibitor targeting the ALDH2-PKC delta axis, eradicates MRD in chronic myeloid leukemia by eliminating leukemia stem cells
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Xiuying Hu, Jishi Wang
Institution: Affiliated Hospital of Guizhou Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417010097
Cites:
Cited by:
Related to: